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Defining the Regulatory Elements in the Proximal
Promoter of DNp63 in Keratinocytes: Potential Roles
for Sp1/Sp3, NF-Y, and p63
Rose-Anne Romano1, Barbara Birkaya1 and Satrajit Sinha1
p63, a homolog of the tumor suppressor p53, plays an important role in the formation of stratified epithelium
such as those in the epidermis of the skin. The p63 gene gives rise to multiple functionally distinct protein
isoforms, including the DNp63 class of isoforms, which lacks the N-terminal transactivation domain and is
synthesized from an internal promoter. DNp63 proteins are the predominant isoforms expressed in
keratinocytes and are thought to be important for maintenance of the proliferative capacity of these cells.
Here, we have examined the transcriptional control mechanisms that govern the expression DNp63 in
keratinocytes. We first performed DNase I hypersensitive site mapping and demonstrated that the promoter
region of DNp63 is in open chromatin state in keratinocytes. To identify the cis-elements that regulate DNp63,
we have performed transient transfection assays in keratinocytes with several DNp63 promoter constructs. This
identified a short evolutionarily conserved fragment that harbors most of the transcriptional activity of the
DNp63 promoter. Biochemical studies of this element have revealed critical roles for CCAAT-box-binding factor
(CBF/NF-Y) and Sp1/Sp3 family of proteins. In addition, our data suggest that DNp63 is recruited to and can
activate its own promoter, possibly through protein–protein interactions, thus providing an auto-regulatory
loop of self-regulation. These studies support the notion that unique and distinct pathways control the
expression of individual p53 family members and their various isoforms.
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INTRODUCTION
The epidermis is the outermost part of the skin that consists
predominantly of keratinocyte cells distributed among multi-
ple layers. The stem cell-like dividing keratinocytes are
present in the basal layer, where they are separated from
the underlying dermis by the basement membrane. Upon
receiving appropriate signals, these cells embark upon a
pre-programmed pathway of differentiation and undergo
distinct changes in cellular morphology, function, and gene
expression patterns (Fuchs and Byrne, 1994). To maintain the
integrity of the skin epidermis, a balance between prolifera-
tion and differentiation of the keratinocytes must be main-
tained during both embryogenesis and adult life. This balance
is controlled by a number of transcription factors, including
p63.
p63 is a recently discovered homolog of the tumor
suppressor protein p53 and exhibits high sequence and struc-
tural homology to p53 as well as to p73, the third member of
the family (Yang et al., 2002). All three proteins exhibit a
modular structure consisting of an amino-terminal transacti-
vation domain (TA), a core DNA-binding domain, and
a carboxyl-terminal oligomerization domain. Interestingly,
unlike p53, p63 has not been shown to function as a classical
tumor suppressor gene; rather it has been implicated in
regulating several developmental processes (Westfall and
Pietenpol, 2004). Indeed, a wide range of p63 mutations
have been associated with many human hereditary disorders
involving ectodermal, craniofacial, and limb malformations
such as EEC (ectrodactyly, ectodermal dsyplasia, and clefting)
syndrome (Brunner et al., 2002). The importance of p63
function in epidermal development and differentiation has
been demonstrated by the dramatic skin phenotype of p63/
mice (Mills et al., 1999; Yang et al., 1999). Similar loss-
of-function experiments in zebra fish have provided clear
evidence that p63 is critical for epidermal development
(Bakkers et al., 2002).
The p63/ mice exhibit a profound block in development
of skin epidermis and lack the characteristic structure of
basal, suprabasal, and cornified layers of the epidermis. The
lack of stratified epithelium and subsequent lack of barrier
formation in p63/ mice results in death owing to severe
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dehydration. This defect in epithelial stratification has led
to the proposal of two hypotheses concerning the potential
role for p63 in epithelial development. According to one
model, p63 may play a critical role in maintaining the stem
cell population in the epithelium. Alternatively, as data from
recent transgenic mouse models suggest, p63 may act as the
master molecular switch for the initiation and commitment
to stratified epithelial lineages (Koster et al., 2004; Koster and
Roop, 2004a).
The p63 gene gives rise to two classes of transcripts
through the use of two distinct promoters: transcripts that
encode for an amino-terminal TA domain and transcripts that
lack this domain (DN). In addition, both the TA and DN
transcripts are differentially spliced at the 30 end to generate
proteins with unique C-termini, which are designated as a, b,
and g isoforms of p63 (Yang et al., 2002). In the skin, p63 is
predominantly expressed in the basal layer of the epidermis,
and recent work by Koster et al. (2004) has suggested that
p63 plays a dual role in the development of the mature
epidermis. According to this model, during embryogenesis,
TAp63, the first isoform that is expressed, is required to
initiate stratification of the epithelium and inhibit terminal
differentiation. Once stratification is initiated, DNp63 levels
increase, which is thought to counterbalance the activity
of TAp63 and allow keratinocytes to respond to signals that
are required for the maturation of the epidermis and commit-
ment to terminal differentiation. These observations suggest a
model in which DNp63 acts as a dominant negative.
However, in the developed epidermis, DNp63 expression
is associated with the undifferentiated proliferative regions
of both normal and neoplastic tissues (Parsa et al., 1999).
Indeed, DNp63 has been shown to be specifically expressed
in keratinocyte stem cells (Pellegrini et al., 2001). In addition,
overexpression of DNp63a in keratinocytes in culture leads
to a block in the expression of differentiation markers, such
as keratin 10 and filaggrin (King et al., 2003). These sets of
data suggest that DNp63 is also important for maintenance
of the proliferative state of keratinocytes.
Although it is quite likely that the levels of DNp63 are
critical for its complex role in epidermal development and
homeostasis developmental processes, to date, very little is
known regarding the regulatory mechanisms by which these
levels are controlled. Cultured keratinocytes predominantly
express the DNp63 isoforms and we have utilized these cells
as a model system to better understand the transcriptional
control mechanisms that govern the expression of DNp63.
Here, we show that the promoter region of DNp63 is in
open chromatin state in keratinocytes and that a short
fragment harbors most of the transcriptional activity of the
DNp63 promoter. Interestingly, this segment shows remark-
able sequence conservation between several species, further
suggesting its functional relevance. Additional studies of this
element have revealed critical roles for CCAAT-box-binding
factor (CBF/NF-Y), Sp1/Sp3 family of proteins, and octamer-
motif-binding (OCT)-like proteins in regulating DNp63.
Finally, our preliminary results also hint at a possible role
of DNp63 in being indirectly recruited to its own promoter
and in self-regulating its own expression.
RESULTS
The intronic promoter of the p63 gene is in open chromatin
conformation in keratinocytes
The DN isoforms of p63 are expressed from an internal
promoter embedded within an intron of the p63 gene. It is
thus highly likely that regions surrounding this site are
involved in transcriptional regulation of the DNp63 class of
isoforms. In order to identify the potential locations of the
cis-elements that regulate DNp63 gene expression, we
analyzed the chromatin conformation by performing DNase
I hypersensitive site mapping. We utilized two independently
isolated mouse keratinocyte (mk) cell lines that predomi-
nantly express DNp63 isoforms, as well as NIH3T3 cells
that do not express any p63. Nuclei isolated from these cell
types were treated with increasing amounts of DNase I and
genomic DNA was isolated. The DNase I-treated genomic
DNA was digested with restriction endonucleases and
Southern blot analysis was performed to identify potential
hypersensitive sites (Hs) within the genomic region corres-
ponding to approximately 1.2 kilobase (kb) upstream and
2.8 kb downstream of the putative DNp63 promoter region.
As shown in Figure 1, DNase I hypersensitive site mapping
revealed that the genomic region encompassing the putative
promoter segment of DNp63 was selectively hypersensitive
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Figure 1. DNp63 promoter exhibits keratinocyte-specific chromatin struc-
ture. Genomic DNA was isolated from mks, mk, and mk2 (two different
sources), and fibroblasts after treatment with increasing amounts of DNase I.
Southern blotting was performed after digestion with BglII and hybridized
with a probe as indicated. The hypersensitive site was observed only with
the keratinocytes (Hs shown by arrow). The lower panel shows a schematic
diagram of the mouse p63 gene locus and the position of the Hs site and
the probe used for the Southern Blot analysis.
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to DNase I in the two keratinocyte cell lines and not in
fibroblasts. These data suggested that the internal promoter
region is in an open chromatin configuration in keratinocytes
and thus likely harbors the binding sites for transcription
factors that regulate DNp63.
Isolation and characterization of the DNp63 proximal promoter
and identification of a conserved segment important for
transcriptional activity
To facilitate analysis of the p63 promoter, we obtained a
BAC clone that contained the genomic segments of the
mouse p63 gene and its flanking regions. We also determined
the putative site of transcriptional initiation by utilizing an
in silico primer extension method that has been recently
reported to be as effective in defining the transcription start
site as conventional methods (Schmid et al., 2004). For this
purpose, we searched the EST (Expressed Sequence Tag)
database to identify multiple DNp63 full-length comple-
mentary DNAs. The clustering of the 50 end of the DNp63
full-length complementary DNAs allowed us to define the
putative transcription start site, which is about 30 base pairs
(bps) downstream of the TATA-box. Based on these data,
we first generated two constructs containing segments –1584
to þ61 (1584Luc) and 703 to þ61 (703Luc) of the
DNp63 promoter upstream of the luciferase reporter gene in
the promoter-less pGL3-basic vector. These two constructs,
1584Luc and 703Luc, were transfected into an mk cell
line along with a CMVLacZ plasmid that served as an internal
control for transfection efficiency. As shown in Figure 2a,
1584Luc promoter construct exhibited strong transcrip-
tional activity (B100-fold compared to the empty vector,
pGL3-basic). There was a drop in activity when the 50 end
was shortened from 1584 to 703, suggesting that regu-
latory elements located in the region between 1584 and
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Figure 2. Deletion studies define the minimal promoter region of DNp63 that displays cell-type specificity. (a) A series of luciferase reporter constructs
containing promoter fragments with various 50 deletions were co-transfected with pCMVLacZ reporter construct into mk cells. After 48 hours, cells were lysed
and assayed for luciferase and b-galactosidase activity. (b) Three representative promoter constructs, 1584Luc, 703Luc, and 164Luc, were co-transfected
with pCMVLacZ into various cell types as indicated, and luciferase and b-galactosidase activities were measured. Promoter activity is normalized for variations
in transfection efficiency using b-galactosidase activity as an internal control. Values are averages with standard deviations of three independent experiments.
The activities of pGL3-basic were set at 1.
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703 might be important in acting as a potential enhancer.
However, 703Luc still retained strong transcriptional
activity. Having shown that the DNp63 promoter was active
in keratinocytes, we decided to test what regions of the
promoter were important for the transcriptional activity. For
this purpose, we generated additional constructs containing
sequentially truncated promoter fragments. Further deletion
at the 50 end from 703 to 164 resulted in no change in
the promoter activity, as the 164Luc construct exhibited
luciferase activity similar to that of 703Luc. However, there
was progressive loss of promoter activity, as additional
50 deletions were made suggesting that multiple transcription
factors were involved in the regulation of the promoter
(Figure 2a). Our data also suggested that the 164Luc
construct, corresponding to a relatively short 255 bps frag-
ment of the promoter (164 to þ61), contained the requisite
sequences that were important for transcriptional activity.
We also wanted to determine if the transcriptional activity
of the DNp63 promoter fragment was restricted to mk
cell lines and whether the activity was cell type specific. To
test this, we transfected three representative constructs,
1584Luc, 703Luc, and 164Luc, into HaCaT cells, a
human keratinocyte cell line that expresses high levels of
DNp63, and non-keratinocyte cell lines NIH3T3 and HeLa
that do not express detectable levels of DNp63. As in
previous experiments, we co-transfected a b-galactosidase
reporter construct to correct for transfection efficiency
between cell lines. The activity of the DNp63 promoter
constructs in NIH3T3 and HeLa cells was significantly lower
as compared to that in HaCaT keratinocytes (Figure 2b). The
data from these transfection studies corroborate our obser-
vation that there is no hypersensitive site in the DNp63
promoter region in p63 non-expressing cell lines such
as NIH3T3 fibroblasts. In addition, these data demonstrate
that the mouse DNp63 promoter is also active in human
keratinocytes, suggesting that the transcriptional control
mechanisms are likely to be conserved. Taken together, our
results indicate that the DNp63 promoter is preferentially
active in keratinocytes and a short 255 bps segment harbors
the necessary cis-elements.
The use of comparative sequence analysis of promoters
from multiple species provides a quick and powerful strategy
to identify critical stretches of nucleotides within a regu-
latory region (Wasserman and Sandelin, 2004). This in silico
approach has become valuable, as genome sequence data
from a large number of organisms are readily available. We
compared the promoter sequence of the mouse DNp63
with the corresponding regions from human, rat, mouse,
cow, dog, and chicken genomes (Figure 3). The promoter
fragment of DNp63, particularly the region upstream of the
TATA-box, showed remarkable sequence similarity among
the six species (almost B97% identity between mouse
and human and B88% between mouse and chicken). In
contrast, sequences beyond this region showed significantly
less sequence conservation between these species (data not
shown). However, the high level of sequence conservation
was not uniform within the 255 bps segment. This allowed
us to focus our further studies on specific regions of the
GATA
CCAAT-box1 CCAAT-box2
−170
Ets POU Ets
TX
TATASp1/Sp3
+45
Dog
Cow
Human
Mouse
Rat
Chicken
Dog
Cow
Human
Mouse
Rat
Chicken
Dog
Cow
Human
Mouse
Rat
Chicken
Dog
Cow
Human
Mouse
Rat
Chicken
Figure 3. The sequences corresponding to the DNp63 promoter are evolutionarily conserved. The sequence of the DNp63 promoter segments from the various
species depicted above was obtained from the respective genome database and aligned using the ClustalW program. The proximal promoter fragment displays
remarkable sequence similarities among the six species as indicated by the * sign. The arrow indicates the putative start site of transcription and the TATA
element is boxed. The putative binding sites for various transcription factors are also indicated.
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DNp63 promoter that were more likely to be of functional
significance, as they exhibited higher levels of sequence
conservation.
Biochemical analysis of the trans-factors that bind to the DNp63
promoter
We first used the Matinspector and Alibaba algorithms to
search the TRANSFAC database to identify potential trans-
cription factor-binding sites present in this segment. This
search revealed the presence of binding sites for a wide range
of transcription factors, including those for Ets, GATA, OCT,
CBF/NF-Y, Sp1/Sp3, proteins that belong to transcription
factor families that are known to be expressed in keratino-
cytes (Figure 3). However, these databases are not compre-
hensive, as the binding sites are not well defined for many
transcription factors and often many transcription factors bind
to sequences that do not match perfectly with their consensus
sequences. Hence, to explore which of these sites specifically
bind nuclear proteins and potentially regulate the activity of
the DNp63 promoter, we conducted electrophoretic mobility
shift assays (EMSA) using several overlapping radiolabeled
oligonucleotides that spanned the DNp63 promoter segment.
The first oligonucleotide that showed specific DNA–
protein complexes with nuclear extracts from keratinocytes
when tested by EMSA contained sequences that matched
consensus Sp1/Sp3-binding sites (Figure 4a, probe A). To exa-
mine if the two complexes were indeed formed by proteins of
the Sp family, we performed competition experiments with
wild-type, consensus Sp1/Sp3, mutant, and random double-
stranded oligonucleotides. Whereas increasing amounts of
wild-type and Sp1/Sp3 consensus oligonucleotides severely
disrupted binding of both the complexes, the mutant
oligonucleotides and random oligonucleotides (containing
activator protein-2 (AP-2) consensus binding sequences) did
not compete (Figure 4a, lanes 2–14). To further confirm the
identity of these complexes, supershift experiments were
performed. These experiments demonstrated that the lower
complex could be completely supershifted with antibodies
against Sp3, whereas the upper complex responded to anti-
bodies against Sp1, albeit weakly (Figure 4a, lanes 16–19).
This suggests that Sp1/Sp3 transcription factors were capable
of binding to the segment of the p63 promoter from 68
to 31.
Two other oligonucleotides that were chosen for EMSAs
were from 126 to 90 and 96 to 56, both of which
contained the CCAAT-box sequences. The CCAAT-box is a
commonly occurring cis-element present in the proximal
promoter of many eucaryotic genes. Typically, this element
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Figure 4. Gel shift analysis reveals the presence of multiple transcription factor-binding sites within the proximal DNp63 promoter fragment. Nuclear extracts
(NE) from mks were used in EMSA. Three separate oligonucleotides spanning the DNp63 promoter used in EMSA are depicted above. The identities of these
proteins are indicated at the right and proteins that bound antibodies (Ab) to form a supershift are denoted by asterisk (*). (a) Sp1/Sp3 binds to probe A. The
unlabeled competing oligonucleotides contained consensus (SP1), a mutated (MUT) Sp1/Sp3-binding site, or an AP-2-binding site (20-, 100-, and 400-fold
excess were used). The complexes were also supershifted with antibodies to Sp1 or Sp3. (b) CBF/NF-Y bound to the oligonucleotide probe B containing the
CCAAT-box1 (CCAAT1). Unlabeled oligonucleotides used in competition assay include a mutant CCAAT1, and a consensus AP-2 used at 100- and 400-fold
excess. The DNA–protein complex was supershifted with antibodies to NF-Y. CCAAT1 probe also bound recombinant NF-Y (GST-NFY), which migrates slower
than the native protein because of the additional GST tag. NS, nonspecific. (c) Binding of OCT factors to probe C. The unlabeled competing oligonucleotides
(100- and 400-fold excess) include a consensus OCT (OCT), a mutant OCT (MUT), or a consensus AP-2-binding site (AP-2). The complex was supershifted with
antibodies to OCT-6.
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is bound and regulated by the trimeric factor NF-Y (also
referred to as CBF), which is composed of three subunits,
NF-YA, NF-YB, and NF-YC, all necessary for DNA binding
(Maity and de Crombrugghe, 1998; Mantovani, 1999). When
tested in EMSA with keratinocyte nuclear extracts, oligo-
nucleotides containing sequences from –126 to –90 (CCAAT-
box1, probe B) bound to a protein complex (Figure 4b, lanes
2–8). This complex was specific as it could be competed by
wild-type oligonucleotide. However, a mutant oligonucleo-
tide containing a 2 bps substitution (CCATC instead of
CCAAT) failed to compete (Figure 4b, lanes 5 and 6). In
addition, as shown in lane 12, recombinant NF-Y (gluta-
thione-S-transferase (GST)-fusion proteins of three subunits)
were also capable of binding to the wild-type oligonucleo-
tide. Finally, we used antibodies against NF-YB to supershift
the complex from keratinocyte nuclear extract as well as
recombinant protein, further confirming that NF-Y present in
the keratinocyte nuclear extracts was capable of binding to
the DNp63 promoter (Figure 4b, lanes 11–13). Similar EMSA
experiments were performed with an oligonucleotide con-
taining the CCAAT-box2 sequences. The results obtained
with mutation and antibody supershift demonstrated that this
region of the p63 promoter was also capable of binding to
NF-Y (data not shown).
Another oligonucleotide that exhibited strong complexes
with keratinocyte nuclear extracts corresponded to sequences
from –152 to –121 (Figure 4c, probe C). As this region con-
tained AT-rich sequences that resembled the consensus
recognition sequence of the POU domain transcription factor
OCT, we examined the complexes by competition assays and
by using specific antibodies. Two strong complexes were
obtained with nuclear extracts from keratinocytes that were
competed by excess amounts of oligonucleotides containing
wild-type and consensus OCT-binding sequences (Figure 4c,
lanes 2–5). In contrast, increasing amounts of mutant or
nonspecific oligonucleotides such as those containing con-
sensus binding sites for AP-2 did not have any effect on these
complexes (lanes 69). As the two major OCT proteins that
are expressed in keratinocytes are Oct-11/Skn-1a and Oct-6/
Tst-1, we tested if these complexes were formed by any
of these two proteins (Andersen et al., 1997). Whereas
antibodies against Oct-11/Skn-1a did not have any effect,
antibodies against Oct-6/Tst-1 led to reduced binding of the
two complexes, and a weak yet distinct supershift (Figure 4c,
lanes 12 and 13). Interestingly, the complexes could not be
completely supershifted or abolished. This could be owing to
the limitation of the antibodies or potentially the presence of
other unknown OCT-like proteins in the complexes. Addi-
tional regions of the DNp63 promoter were also probed for
binding to nuclear proteins; however, no specific complexes
were detected (data not shown).
Functional assay of the transcription factor-binding sites
in transient transfection experiments: mutations that affect
the promoter activity
Identification of potential binding sites for the various trans-
cription factors, NF-Y, Sp1/Sp3, and Oct-6, led us to question
whether these sites play a functional role in activation of the
DNp63 promoter in keratinocytes. To test this, we generated
several mutant reporter constructs spanning the promoter
segment in the luciferase reporter construct (164Luc) and
analyzed them in transient transfection experiments in
keratinocytes. These mutations were identical to the mut-
ations that were tested in EMSA experiments and were shown
to have a significant reduction in binding activity as judged
by either competition assays or by direct binding (Figure 4
and data not shown). Mutation of the Sp1/Sp3 site had a
dramatic effect on the promoter activity, as there was a 95%
drop in the luciferase activity (Figure 5). This suggested that
the Sp1/Sp3 site was critical for the DNp63 promoter activity.
Interestingly, mutation of either the CCAAT-box1 or CCAAT-
box2 also had a profound effect on the promoter activity. On
the other hand, mutation of the OCT site had only a modest
decrease in activity. We also tested two additional mutations
that contained core GGA motifs that are putative binding sites
for Ets proteins (see Figure 3). Mutation of these potential
Ets-binding sites (one at 152 and one at 114) had no effect
on the promoter activity, suggesting that these Ets-binding
sites are probably not important. Taken together, our mut-
ational analysis indicates that mutation of any of the CCAAT-
box- or the Sp1/Sp3-binding sites was sufficient to disrupt the
DNp63 promoter activity. These results are strongly sugges-
tive of a cooperative binding of NF-Y/CBF and Sp1/Sp3 to the
promoter region, such that disruption of binding of any one
factor leads to strong destabilization of the transcriptional
machinery.
In vivo occupancy of the DNp63 promoter by transcription
factors
Finally, we tested the binding of these transcription factors
to the DNp63 promoter in mks by performing chromatin
immunoprecipitation (ChIP) experiments. For the ChIP
assays, crosslinked chromatin from mks was immunopreci-
pitated with respective antibodies, and the abundance of the
DNp63 promoter sequences was measured by PCR. We
utilized a set of primers (P1 and P2) that amplify the proximal
promoter region of the DNp63 promoter and as a control;
we used a set of primers (P3 and P4) that amplify a segment
that is approximately 4 kb upstream of the DNp63 promoter
(Figure 6a). As shown in Figure 6b, after immunoprecipitation
of formaldehyde-crosslinked chromatin with antibodies
against NF-YB, there was clear enrichment of the DNp63
promoter region in contrast to the control as evident from the
PCR results. Similar results were also obtained with anti-
bodies against Sp1 and Sp3. In both cases, there was a signi-
ficantly stronger band, compared to background. Despite our
attempts, we were unable to perform successful immmuno-
precipitation with the antibodies directed against Oct-6.
These data indicate that in vivo the transcription factors NF-Y/
CBF, Sp1, and Sp3 are associated with the DNp63 promoter
region in mks.
Recruitment of DNp63 to its own promoter and activation
of the minimal promoter by p63
Many transcription factors including DNp73 have been shown
to autoregulate their own promoter (Nakagawa et al., 2002). It
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has been reported that p63 protein can bind to p53 consensus
binding sequences. Hence, we investigated if DNp63 can
bind to its proximal promoter. For this purpose, we utilized
overlapping oligonucleotides that spanned the entire minimal
promoter. However, EMSA experiments failed to detect any
direct binding of DNp63 to the promoter region, in agreement
with the lack of a p53 consensus binding site. It is possible
that DNp63 can bind to unique DNA sequences that are
distinct from p53 or may be recruited to the promoter
indirectly through protein–protein interaction. To test this
hypothesis, we first performed ChIP experiments with an
antibody RR14, which is specific for an N-terminal peptide
that is unique to DNp63 and hence will recognize only this
isoform (see Figure S1). As shown in the lower panels of
Figure 6b, PCR results showed that antibodies against DNp63
specifically immunoprecipitated the promoter region and not
the distal region. To confirm these data, we repeated the ChIP
experiments with two other p63 antibodies, 4A4 monoclonal
and the H-129 polyclonal. These antibodies are directed
against N-terminal amino acids 1–205 of human p63 (4A4)
and C-terminal amino acids 513–641 of the p63 protein
(H-129), respectively. Thus, the 4A4 antibody recognizes all
p63 isoforms, as it recognizes the DNA-binding domain,
whereas H-129 recognizes the p63a isoforms, as it is directed
against the C-terminus SAM domain. The results obtained
from ChIP experiments with these antibodies were similar,
strongly reinforcing the notion that DNp63 is recruited to its
own promoter.
Finally, to test the effect of p63 on its own promoter, we
performed transient transfection experiments in Ptk2 cells
which do not express p63. The DNp63 minimal promoter
construct 164Luc was transfected into Ptk2 cells along with
either control expression plasmid pCMVHA or plasmids that
expressed various isoforms of p63. A CMVLacZ plasmid was
co-transfected to serve as an internal control for transfection
efficiency. As data presented in Figure 6c indicate, expression
of both DNp63a and DNp63g isoforms led to higher trans-
criptional activity of the DNp63 minimal promoter (three- to
five-fold, respectively compared to the empty vector). Simi-
larly, the TA isoforms also showed activation of the 164Luc
construct, although the fold induction of activity was modest
compared to the DN isoforms (two-fold). These data suggest
that DNp63 may thus regulate its own expression at the
transcriptional level.
DISCUSSION
The spatial and temporal expression of p63 is largely
restricted to epithelial tissues. Indeed, gain-of-function and
loss-of-function experiments have demonstrated that the p63
gene is critical for the development of stratified squamous
epithelium (Koster and Roop, 2004b). Multiple transcripts of
the p63 gene are expressed as a result of alternative splicing
or dual promoter usage. The dual promoter structure of p63 is
also shared by its close relative, p73. Thus, both p63 and p73
have two promoters, P1 upstream of exon 1 and P2 located
within a large intron 3 that can initiate transcription from an
alternate exon. The use of these two promoters leads to the
generation of two opposing classes of proteins: those that
contain the TA domain, such as TAp63 and TAp73, and those
that lack it, such as DNp63 and DNp73. It is thought that the
balance between the two isoforms of each protein plays an
important role in cellular proliferation and differentiation
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Figure 5. Mutational analysis of the DNp63 minimal promoter. The DNp63 core promoter was scanned for putative transcription factor-binding sites and
mutations were generated based on EMSA and database search (denoted by X). Wild type and mutant plasmids were transfected into mks along with pCMVLacZ
reporter construct, and luciferase activities were determined and normalized against b-galactosidase values. The value of the –164Luc was set at 100.
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programs and hence the activity of the promoters is likely to
be tightly controlled. Thus far, the TAp73 promoter has been
characterized and has been shown to be regulated by the E2F
family of proteins (Seelan et al., 2002). In addition, recent
studies have shed light on transcription factors that regulate
the DNp73 promoter (Nakagawa et al., 2002). However, to
date, relatively little is known about the factors that control
the expression of either p63 promoter. Here, using mks as a
model system, we have characterized the promoter of
DNp63, which is the predominant isoform expressed in these
cells.
Our initial studies identified the presence of a DNase I
hypersensitive site at the location corresponding to the
DNp63 promoter, suggesting that this region is in an open
chromatin conformation, as would be expected if this was
a functional regulatory region. Interestingly, this region is
accessible to the transcriptional machinery only in p63-
expressing cells, such as keratinocytes as opposed to fibro-
blasts. The identification of a short segment of the DNp63
promoter that showed robust keratinocyte-specific transcrip-
tional activity allowed us to examine these sequences in
more detail. First, we performed bioinformatics analysis
by comparing the corresponding sequences from several
species, which showed that the DNp63 promoter sequences
were highly conserved as would be expected for regulatory
elements that are critical for expression. Second, we
performed biochemical analysis of this segment by perform-
ing EMSA assays. The data obtained from the EMSA analysis
allowed us to perform mutational studies in transient
transfections to test and identify the elements that govern
DNp63 promoter activity. Finally, we performed ChIP experi-
ments to confirm the in vivo relevance of the transcription
factors that regulate DNp63 promoter activity in keratino-
cytes.
Our data suggest that the DNp63 promoter is regulated
by a multitude of transcription factors including Sp1/Sp3 and
CCAAT-box-binding factor NF-Y/CBF. Interestingly, many
studies have shown that the Sp1 and Sp3 proteins are
involved in the regulation of genes involved in keratinocyte
differentiation program (Jessen et al., 2000; Sinha et al., 2000;
Santini et al., 2001; Jang and Steinert, 2002; Wong et al.,
2005). It has been thought that the relative levels of Sp1 and
Sp3 may contribute to the keratinocyte differentiation state as
suggested by the fact that Sp3 levels are higher in the basal
cells, whereas Sp1 levels are elevated upon differentiation
(Wong et al., 2005). Although Sp1 and Sp3 are expressed in
multiple cell types, it is conceivable that they may have
specific gene regulatory functions in keratinocytes. This may
be mediated by cell-type-specific modifications of these
proteins or interaction with coactivators that are expressed
only in keratinocytes. The knockout models for Sp1 and Sp3
have failed to address any potential role of these factors in
skin keratinocyte development and differentiation, because of
embryonic lethality and the potential for functional redun-
dancy. The role of NF-Y/CBF in regulating keratinocyte-
specific genes has also not been elucidated at this moment.
However, it is interesting to note that NF-Y/CBF has been
implicated in regulating several cell cycle regulatory genes
and thus controlling cell cycle progression at both G1/S and
G2/M boundaries (Caretti et al., 2003; Imbriano et al., 2005).
As p63 is intimately involved in cell proliferation, it is
possible that the regulation of one of its isoforms is closely
linked with the transcriptional machinery that governs these
cellular processes, in part through NF-Y/CBF. Our mutational
analysis suggests that NF-Y/CBF and Sp1/Sp3 are critical
mediators of the DNp63 promoter activity and may act in a
cooperative fashion, as mutation in either site results in
dramatic loss of promoter activity. This cooperative nature
of interaction between NF-Y/CBF and Sp1/Sp3 has also been
described for other promoters (Ge et al., 2001; Iwano et al.,
2001).
One interesting observation from our ChIP experiments is
the association of DNp63 protein with its own proximal
promoter region. This is surprising because we have not
found any p63-binding site within the promoter, suggesting
that the recruitment of DNp63 protein may not be mediated
directly through sequence-specific DNA binding but rather
through protein–protein interactions. In this context, both
NF-Y/CBF and Sp1/Sp3 are likely to be good candidates to
mediate this interaction. In one recent study, DNp63 protein
was shown to upregulate the expression of hsp70 gene
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Figure 6. Analysis of the DNp63 minimal promoter by ChIP reveals
occupancy of the promoter by transcription factors and self-activation by
p63. (a) A schematic representation of the DNp63 gene showing the locations
of the primers used for the PCR. (b) ChIP was performed in mks with
antibodies against various transcription factors as well as non-specific IgG,
as indicated. Input represents PCR amplification of 1% of the genomic DNA.
Ethidium bromide-stained gel shows one representative result of at least
three independent experiments. (c) Np63 minimal promoter (164Luc) was
co-transfected with expression plasmids encoding various hemogglutinin-
tagged p63 proteins into Ptk2 cells. Luciferase values were determined and
normalized against b-galactosidase values. The corrected luciferase values
for cells transfected with empty vector pCMV-HA were set at 1.
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expression through the CCAAT-box in the hsp70 promoter,
and a direct interaction of DNp63 protein and NF-Y complex
was demonstrated (Wu et al., 2005). Similarly, studies on
the p21 promoter have demonstrated interactions between
Sp1/Sp3 and the p53 family members (Koutsodontis et al.,
2005).
One previous study has shown the presence of a putative
p53/DNp63 binding site in the 629 to 607 region of the
human DNp63 promoter (Harmes et al., 2003). The authors
show that in mammary epithelial cells, this site is occupied
by p53, which mediates a positive transactivation effect.
In response to DNA damage, DNp63 protein is recruited to
this element, where it acts as a repressor. However, the
authors also report that overexpression of DNp63 enhances
the activity of the DNp63 promoter in a manner that is
independent of the p53-binding site. Our ChIP and transient
transfection data suggest that this enhancement of the
promoter activity could be mediated through the recruitment
of DNp63 to the proximal promoter. A recent study has also
implicated dEF1 repressor, the vertebrate homolog of the
Drosophila zinc-finger homeodomain factor, zfh-1, in con-
trolling the expression of DNp63 (Fontemaggi et al., 2005). In
this study, dEF1 was shown to occupy the DNp63 promoter
region preferentially during keratinocyte differentiation. This
raises the intriguing possibility that as keratinocytes differ-
entiate, the transcriptional machinery switches from one
that maintains a proliferative state, possibly mediated by
NF-Y/CBF and Sp1/Sp3, to one that contains dEF1 where it
represses the DNp63 activity.
Although the proximal promoter exhibits some levels of
keratinocyte-specific activity in transient transfection experi-
ments, it is likely that for faithful in vivo expression of DNp63,
additional regulatory elements are needed. Indeed, some of
our preliminary unpublished data point in that direction.
First, we have detected additional DNase I hypersensitive
sites that correlate with some of the conserved non-coding
sequences of the p63 gene in locations that are further away
from the promoter region. Second, a reporter construct
containing a 2.6 kb fragment of the DNp63 promoter fails to
display faithful expression in skin keratinocytes in transgenic
animals, suggesting that additional elements are necessary
(our unpublished data). Thus, as expected, the transcriptional
regulatory network that governs the expression of DNp63
is quite complex and involves multiple players. However,
our initial studies on the proximal promoter have provided
a glimpse of how these transcriptional regulators act and have
set the stage for further studies in understanding how the
expression of DNp63 is regulated in keratinocytes.
MATERIALS AND METHODS
DNase I hypersensitive site mapping
DNase I hypersensitive site mapping was performed as described
previously (Sinha, 2004). Briefly, nuclei were obtained from
keratinocytes and NIH3T3 fibroblasts and subjected to increasing
amounts of DNase I treatment. Genomic DNA was purified and
digested with BglII and Southern blot was performed with Zeta-
Probe GT membrane by using the manufacturer’s protocol (Bio-Rad,
Hercules, CA).
Cell culture
HeLa, NIH3T3, and HaCaT cells were grown in DMEM supple-
mented with 10% fetal bovine serum and 100 U/ml penicillin and
100mg/ml streptomycin. Ptk2 (rat kangaroo kidney epithelial) cells
were grown in minimal essential medium supplemented with 10%
fetal bovine serum, 1% MEM non-essential amino-acid solution,
100 U/ml penicillin, and 100 mg/ml streptomycin. A spontaneous
immortalized mk cell line (also known as UG-1) was grown in a low
Ca2þ medium comprised of a 3:1 mixture of Ham’s F12 and DMEM
supplemented with 15% chelated fetal bovine serum. A second
mouse keratinocyte cell line (mk2) that has been established by
our laboratory was used for the DNase I Hs mapping experiments.
mk2 keratinocytes were established from new born mouse skin by
utilizing serum-free CnT-02 medium (CeLLnTECH Advanced
Cell systems, Switzerland). After a few passages, the mk2 cells
were switched to low Ca2þ medium for experimental purposes. The
keratinocytes grown in cultures were periodically assessed by
morphological appearances, differentiation response to high Ca2þ
levels, and expression of keratinocyte markers and of p63.
Preparation of nuclear extracts and EMSAs
Nuclear extracts were prepared by standard methods. Briefly, cells
were scraped from dishes into isotonic cold phosphate-buffered
saline and collected by centrifugation at 1,850 g for 10 minutes.
The pellet was resuspended in 5 volume of buffer A (10 mM HEPES
pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM dithiothreitol, and freshly
added protease inhibitors). Cells were incubated on ice for
10 minutes and centrifuged at 1,850 g for 10 minutes. The pellet
was resuspended in 2 volume of buffer A and homogenized using
Dounce Homogenizer (10–15 strokes). Nuclei were pelleted by
centrifuging for 2 minutes at 12,000 g. Nuclei were resuspended in
2 volume of high-salt buffer B (20 mM HEPES, 25% glycerol,
1.5 mM MgCl2, 0.45 M NaCl, 0.2 mM EDTA, 1 mM dithiothreitol, and
freshly added protease inhibitors) and rotated end on end on a Rota-
Mixer for 30 minutes at 41C. Nuclear extracts were collected from
the supernatant by centrifugation in a microcentrifuge at 13,500 g
for 30 minutes, flash frozen, and stored at 801C.
For EMSAs, complementary oligonucleotides spanning the
regions of interest were synthesized (IDT Technologies), annealed,
and 2 pm of double-stranded oligonucleotides was used for radio-
active labeling with [a-32P]dCTP. A 1–3 bps 50 overhang was desig-
ned at each end to allow labeling by fill-in with Klenow polymerase.
After labeling, probes were purified using G-50 Nick columns
(Amersham, Piscataway, NJ). Binding reactions were performed at
room temperature in 20 ml of DNA-binding buffer (20 mM HEPES, pH
7.9, 75 mM KCl, 10% glycerol, 1 mM DTT, and 2.5 mM MgCl2) with
4–6 mg of nuclear extracts. One microgram of poly(dA-dT) or poly
(dI-dC) was added as a nonspecific DNA competitor. For probe B,
EMSAs were also performed with recombinant GST-fusion proteins.
GST-CBF-A/C and GST-CBF-B (a gift from Dr Sankar Maity) were
expressed and purified from E. coli using routine GST purification
techniques. For competition assays, keratinocyte nuclear extracts
were preincubated with competitor oligonucleotides (20-, 100-, or
400-fold excess) for 20 minutes before addition of labeled probe. For
supershift assays, antibodies were preincubated with nuclear extracts
for 20 minutes at room temperature before addition of labeled probe.
The following antibodies were used: Oct-6 (H-13), Skn-1A (C-20),
Sp1 (PeP-2), Sp3 (D-20) (from Santa Cruz, CA), and NF-YB (gift from
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Dr Mantovani). The protein–DNA complexes were resolved by gel
electrophoresis on 5% non-denaturing polyacrylamide gels at room
temperature. Gels were dried and visualized by autoradiography.
The following oligonucleotide probes were used in EMSAs (muta-
tions are in bold):
probe A: 50-GGTAAAGTGAAGAGTCCCGCCCCTCATGCCT
ATAGTTGG-30
MUT probe A: 50-GGTAAAGTGAAGAGTCCCGCTTATCATGCCT
ATAGTTGG-30
probe B: 50-GAGAGGCCTCACTCCATTGGAGTGGAGGAG
CCCAGG-30
MUT probe B: 50-GAGAGGCCTCACTCCGATGGAGTGGAGGAG
CCCAGG
probe C: 50-GGAATTCTAACTACTTAATGAGATGGGAGA
G-30
MUT probe C: 50-GGAATTCTAACTACTCGGTGAGATGGGAGA
G-30
Construction of p63 promoter and expression plasmids
The various promoter segments were cloned into pGL3-basic vector
(Promega, Madison, WI) by using restriction enzymes KpnI and XhoI
that were introduced by PCR. A mouse BAC clone RP23-186N8
containing the DNp63 genomic DNA was used as a template for
PCR and was obtained from BACPAC Resources. Mutations in the
164Luc proximal promoter construct were introduced by using
a two-step PCR-based method that has been described previously
(Sinha et al., 2000). All constructs were verified by sequencing. The
mutations that were generated for the SP1/SP3-, CCAAT1-, and OCT-
binding sites were the same as described for the MUT probe A, B,
and C, respectively. Additional mutations are as follows: ETS1
mutation: (GATAAGGAATTC4GATAATTGATTC), ETS2 mutation:
(CTCACTCCATTG4CTCACGACATTG), and CCAAT2 mutation:
(TGGATTGGACAG4TGGATACGACAG). The expression plasmids
for the various p63 isoforms (DNp63a, DNp63g, TAp63a, and
TAp63g) were generated by cloning the respective complementary
DNAs into the BglII–NotI site of the pCMV-HA vector. The comple-
mentary DNAs were obtained by searching the expressed sequence
tag database and were modified by PCR strategy for creating
in-frame fusion with the hemagglutinin tag. All plasmids were
sequenced with vector- and insert-specific oligonucleotides at the
Roswell Park DNA sequencing Core facility.
Transient transfections and reporter assays
mk, HeLa, HaCaT, Ptk2, and NIH3T3 cells were plated 24 hours
before transfection in six-well plates. Transfections were performed
when cells were 30–50% confluent and in proliferative states using
Fugene 6 reagent (Roche, Indianapolis, IN) according to the manu-
facturer’s instructions. One microgram of each luciferase reporter
construct was transfected per well along with 0.5 mg of pCMVLacZ
plasmid DNA to serve as an internal control for transfection
efficiency. After 48 hours, cells were scraped and lysed in Reporter
Lysis Buffer (Promega, Madison WJ). Cell extracts were assayed for
luciferase activity using Luciferase Assays System (Promega,
Madison, WJ) and for b-galactosidase activity using the Galacton
Plus Kit (Tropix) as per the manufacturer’s instructions. Transfection
studies were performed in duplicate, and a minimum of three
independent experiments were performed for each construct.
Luciferase activity was normalized to the b-galactosidase activity
and average values were determined.
Bioinformatics and in silico data analysis
The sequences for the promoter region of DNp63 from different
species were obtained by performing a BLAST search of the genome
database available at NCBI. The sequences were then aligned using
CLUSTALW program (http://www.ebi.ac.uk/clustalw). The Matin-
spector (http://www.genomatix.de) and Alibaba2.1 (http://www.
alibaba2.com) programs were used for transcription factor-binding
site prediction.
ChIP assays
Keratinocytes were crosslinked with 1% formaldehyde (Sigma, St
Louis, MO) at 371C for 10 minutes, rinsed twice with cold
phosphate-buffered saline, and then harvested in phosphate-buffered
saline with protease inhibitors by centrifugation for 5 minutes at
2,000 g. Cells were then lysed in ChIP lysis buffer (50 mM Tris-HCl
(pH 8.1), 1% SDS, and 10 mM EDTA) and sonicated 15–20 times with
30-second cycles at setting 3 (Branson Sonifier 250) to generate
chromatin fragments of 0.5 kb on average. Sonicated samples were
centrifuged for 10 minutes at 12,000 g and the supernatant was
diluted 10-fold in immunoprecipitation buffer (10 mM Tris-HCl (pH
8.1), 1% Triton X-100, 0.1% deoxycholate, 0.1% SDS, 90 mM NaCl,
and 2 mM EDTA). Two hundred and fifty micrograms of chromatin
DNA was subjected to a 1 hour preclearing with 50 ml of a 50%
protein A-Sepharose bead slurry containing sheared salmon sperm
DNA and BSA (Upstate, Charlottesville, VA). The precleared samples
were then immunoprecipitated overnight with 5–10 mg of antibodies
at 41C. The immune complexes were then incubated for 1 hour at
41C with 50ml of fresh protein A-Sepharose beads. Following
incubation, the beads were collected by centrifugation for 3 minutes
at 3,000 g and washed consecutively for 3–5 minutes with 1 ml of
each solution: low-salt wash buffer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM Tris pH 8.1, and 150 mM NaCl), high-salt wash
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris pH 8.1,
and 500 mM NaCl), LiCl wash buffer (250 mM LiCl, 1% NP-40, 1%
deoxycholate sodium salt, 1 mM EDTA, and 10 mM Tris pH 8.1), and
twice in Tris and EDTA buffers (10 mM Tris pH 8.1 and 1 mM EDTA).
Immune complexes were then eluted with 250 ml of buffer contain-
ing 1% SDS and 100 mM NaHCO3. Crosslinking was reversed by
incubating the samples overnight at 651C. Genomic DNA was
precipitated with ethanol and after treatment with RNase A and
proteinase K, purified using Qiagen PCR purification kit. PCR was
then performed on the immunoprecipitated genomic DNA with
primers for the promoter region of DNp63 and with control primers
for a region 4 kb upstream of the promoter. The antibodies used for
the various transcription factors were the same as described
previously for EMSA experiments. For ChIP experiments with anti-
p63, 4A4, and H-129, antibodies were obtained from Santa Cruz.
The RR14 antibodies were generated in our laboratory against a
peptide ENNAQTQFSEPQYC that is present only in the DNp63
isoform. Antisera were generated by subcutaneous injection of
peptide conjugate emulsified with Freunds adjuvant into New
Zealand White rabbits (Sigma Genosys, St Louis, MO). The serum
from the immunized rabbits was subjected to peptide purification
and the antibodies were tested for specificity by Western blot
analysis. Primers used for PCR are P1 (50-CTAAGAAGATAACAGAA
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TTCAGGTG-30), P2 (50-CTACTTAATGAGATGGGAGAGGCC-30),
P3 (50-CACCAGTGTGGCACAGAGGAAAGG-30), and P4 (50-GCTCT
GGGCTGTGGGGACTTTCCG-30).
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